Skip to content

Hold Aurobindo Pharma; target of Rs 540: ICICI Direct

ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 540 in its research report dated November 14, 2022.

Read More

Leave a Reply

Generated by Feedzy
en_USEnglish
%d bloggers like this: